Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Brian Laufer
Best Evidence in Anesthetic Practice Prevention: Recombinant Human Activated Protein C Reduces Mortality in Severe Sepsis
Canadian Journal of Anaesthesia
Medicine
Anesthesiology
Pain Medicine
Related publications
Activated Protein C in Severe Sepsis
Intensive and Critical Care Nursing
Critical Care Nursing
Best Evidence in Anesthetic Practice Prevention: Dimenhydrinate Prevents Postoperative Nausea and Vomiting
Canadian Journal of Anaesthesia
Medicine
Anesthesiology
Pain Medicine
Changes in Protein C Activity in Severe Sepsis.
Nihon Kyukyu Igakukai Zasshi
A Long-Term Follow-Up Study Investigating Health-Related Quality of Life and Resource Use in Survivors of Severe Sepsis: Comparison of Recombinant Human Activated Protein C With Standard Care
Critical Care
Critical Care
Intensive Care Medicine
Surviving Ratio of Severe Sepsis Treated With Activated Protein C in One University Intensive Care Unit During 2003–2006
Critical Care
Critical Care
Intensive Care Medicine
Activated Protein C Reduces Myocardial Infarct Size and Infarct Expansion in Rats
Heart Lung and Circulation
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Cardiology
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy
JAMA - Journal of the American Medical Association
Medicine
Exchange Transfusion in Neonatal Sepsis Dose Not Reduces Overall Mortality
Journal of Evolution of Medical and Dental Sciences
Introduction: Severe Sepsis and Drotrecogin Alfa (Activated)
Critical Care
Critical Care
Intensive Care Medicine
